Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
27.88
-0.06 (-0.21%)
Feb 4, 2026, 10:14 AM CST

SHA:688566 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
957.76896.53860.93654.73509.69565.97
Revenue Growth (YoY)
7.96%4.13%31.49%28.46%-9.94%4.32%
Cost of Revenue
100.4395.2697.1876.1762.1264.06
Gross Profit
857.33801.28763.76578.56447.57501.91
Selling, General & Admin
537.92458.54459.86361.56304.65326.75
Research & Development
37.738.6555.7755.1829.2833.55
Other Operating Expenses
14.7812.9810.479.249.19.89
Operating Expenses
590.1512.43533.31426.71341.26373.28
Operating Income
267.22288.85230.44151.85106.32128.63
Interest Expense
-0.23-0.13-0.11-0.38--
Interest & Investment Income
5.755.412.0217.7721.6419.51
Other Non Operating Income (Expenses)
0.45-0.11-0.14-0.07-0.11-0.11
EBT Excluding Unusual Items
273.2294.01242.22169.18127.85148.02
Gain (Loss) on Sale of Investments
-1.2-1.05-1.9---
Gain (Loss) on Sale of Assets
----0.01-0
Asset Writedown
-42.24-42.24----
Other Unusual Items
50.962.657.165.374.710.51
Pretax Income
280.72253.36247.48174.53132.56148.53
Income Tax Expense
40.1934.3928.7120.2718.2218.67
Earnings From Continuing Operations
240.53218.98218.77154.26114.35129.86
Minority Interest in Earnings
1.140.350.320.40.55-0.14
Net Income
241.67219.33219.09154.67114.9129.72
Net Income to Common
241.67219.33219.09154.67114.9129.72
Net Income Growth
1.29%0.11%41.65%34.61%-11.42%14.88%
Shares Outstanding (Basic)
199194187186188168
Shares Outstanding (Diluted)
199194187186188168
Shares Change (YoY)
4.39%3.65%0.49%-1.07%11.81%20.85%
EPS (Basic)
1.211.131.170.830.610.77
EPS (Diluted)
1.211.131.170.830.610.77
EPS Growth
-2.97%-3.42%40.96%36.07%-20.78%-4.94%
Free Cash Flow
74.5340.76-197.87-141.9866.7793.68
Free Cash Flow Per Share
0.370.21-1.06-0.760.350.56
Dividend Per Share
0.5200.780-0.4800.4800.480
Gross Margin
89.51%89.38%88.71%88.37%87.81%88.68%
Operating Margin
27.90%32.22%26.77%23.19%20.86%22.73%
Profit Margin
25.23%24.46%25.45%23.62%22.54%22.92%
Free Cash Flow Margin
7.78%4.55%-22.98%-21.68%13.10%16.55%
EBITDA
277.37299.45241.65164.6119.3141.93
EBITDA Margin
28.96%33.40%28.07%25.14%23.41%25.08%
D&A For EBITDA
10.1510.611.212.7512.9813.3
EBIT
267.22288.85230.44151.85106.32128.63
EBIT Margin
27.90%32.22%26.77%23.19%20.86%22.73%
Effective Tax Rate
14.32%13.57%11.60%11.62%13.74%12.57%
Revenue as Reported
957.76896.53860.93654.73509.69565.97
Advertising Expenses
---153.2121.29142.98
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.